168
Participants
Start Date
April 30, 2024
Primary Completion Date
August 31, 2024
Study Completion Date
September 30, 2024
Intrathecal Bupivacaine-Fentanyl and Bupivacaine-Dexmedetomidine
In patients undergoing elective LSCS under subarachnoid block, group BF will receive 0.5% hyperbaric bupivacaine 10mg (2ml) with fentanyl 10 mcg (0.2ml) with total of 2.2 ml and group BD will receive 0.5% hyperbaric bupivacaine 10 mg with Dexmedetomidine 5mcg (0.2ml) total volume 2.2ml. Assessment of intraoperative visceral pain will be done by self-reporting of patients, who are previously educated, as poorly localized discomfort or dragging, pulling heaviness or unpleasant feeling or pain with or without nausea and will be categorized according to preformed scale.
Tribhuvan University Teaching Hospital, Institute Of Medicine.
OTHER